Register entry
ZEVRA DENMARK AS
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 16
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
16| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 9884058 | MIPLYFFAarimoclomol citrate | use | Jun 2029 |
| 9289472 | MIPLYFFAarimoclomol citrate | use | Aug 2029 |
| 11045460 | MIPLYFFAarimoclomol citrate | use | Aug 2029 |
| 11707456 | MIPLYFFAarimoclomol citrate | substance, product | Nov 2041 |
| Product | Exclusivity | Until |
|---|---|---|
| MIPLYFFAARIMOCLOMOL CITRATE | ODE-496 Orphan drug | Sept 2031 |
Enquiry
Common questions
- Is ZEVRA DENMARK AS FDA approved?
- ZEVRA DENMARK AS holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.